Related Experiment Videos
Clinical experiences with nimodipine in cerebral ischemia
A Kakarieka1, E H Schakel, J Fritze
1Medical Research CNS, Troponwerke GmbH & Co. KG, Köln, Federal Republic of Germany.
Journal of Neural Transmission. Supplementum
|January 1, 1994
Summary
Calcium channel blockers like nimodipine may protect neurons from death during cerebral ischemia. Clinical trials explored its use in subarachnoid hemorrhage, head injury, and stroke, showing potential therapeutic benefits.
Area of Science:
- Neuroscience
- Pharmacology
- Clinical Medicine
Background:
- Elevated intracellular calcium levels contribute to neuronal death in cerebral ischemia.
- Calcium antagonists are a potential therapeutic strategy for cerebrovascular disorders.
Purpose of the Study:
- To review clinical trials investigating the efficacy of nimodipine in cerebrovascular conditions.
- To assess the role of nimodipine in managing outcomes related to cerebral ischemia.
Main Methods:
- Overview of existing clinical trial data on nimodipine.
- Focus on patient populations with subarachnoid hemorrhage, head injury, ischemic stroke, and cerebral resuscitation.
Main Results:
- Nimodipine has been evaluated in multiple clinical trials for cerebrovascular disorders.
- The drug's potential benefits in specific neurological conditions are under investigation.
Conclusions:
- Nimodipine shows promise as a neuroprotective agent in cerebrovascular diseases.
- Further research and clinical application are warranted based on trial outcomes.